Skip to Main Content

Katherine Seley-Radtke

radkeProfessor of Chemistry and Biochemistry
NIH-funded research employs a chemical biology approach to nucleoside and heterocyclic drug discovery and development with therapeutic emphasis on antiviral, anticancer and antiparasitic targets and overcoming resistance to currently used drugs. Serves as the Program Director for UMBC’s Chemistry-Biology Interface graduate training program funded by NIH. She is currently the Vice-President (and President-Elect) for the International Society of Nucleosides, Nucleotides and Nucleic Acids. Standing member of the NIH AIDS Drug Discovery and Development Study section, a member of the American Chemical Society’s Medicinal Chemistry Division’s awards committee and a Board member of the International Society for Antiviral Research. Also serves as an Associate Editor for Current Protocols in Chemical Biology. As one of the Jefferson Science Fellows for the National Academies of Sciences and the U.S. Department of State, she works with the U.S. Government and the U.S. Embassy in Moscow on a number of scientific issues including the changing landscape of Russian science, emerging and reemerging infectious diseases, and the nonproliferation of biological and chemical weapons. Dr. Seley-Radtke is the 2015-2018 Presidential Research Professor.

Learn More >>

Back to full faculty page >>